Evidence map›Paper›PMID 23079675›Full record

ReviewCurrent opinion in gastroenterology2012

Where are we on worms?

David E Elliott, Joel V Weinstock

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Immuno-therapeutic and prophylactic potential ofFood and waterborne parasitology · 2024
    Article
  5. Article
  6. Current and emerging therapies for coeliac disease.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Human Helminths and Allergic Disease: The Hygiene Hypothesis and Beyond.The American journal of tropical medicine and hygiene · 2016
    Review
  15. Review
  16. Article
  17. Article
  18. Role of type 2 immunity in intestinal inflammation.Current opinion in gastroenterology · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

David E ElliottDivision of Gastroenterology, University of Iowa Carver College of Medicine and VAMC, Iowa City, Iowa 52242, USA. david-elliott@uiowa.edu
Joel V Weinstock
Tufts Medical Center · USUniversity of Iowa · US

Funding

Helminthic Protection From IBDR01DK058755 · NIDDK · UNIVERSITY OF IOWA · PI WEINSTOCK, JOEL VINCENT · 2001 to 2013
$4.1M
Induction of Regulatory T Cells to Control IBDR01DK091987 · NIDDK · TUFTS MEDICAL CENTER · PI WEINSTOCK, JOEL VINCENT · 2011 to 2014
$1.4M
Helminthic Protection From IBDR56DK058755 · NIDDK · TUFTS MEDICAL CENTER · PI WEINSTOCK, JOEL VINCENT · 2009 to 2009
$485k
NIDDK NIH HHS DK058755NIDDK NIH HHS DK091987NIDDK NIH HHS R01 DK058755NIDDK NIH HHS R01 DK091987NIDDK NIH HHS R56 DK058755
6 · The paper itself

Abstract

purpose of reviewThere is something about living in an industrialized country that dramatically increases the risk of acquiring inflammatory bowel disease (IBD). Loss of routine exposure to parasitic worms (helminths), due to modern highly hygienic life styles, likely contributes to this risk. This article reviews current understanding on how helminths influence intestinal inflammation and mucosal immune responses. RECENT

findingsIBD emerges in populations as regions develop socioeconomically and lose exposure to previously ubiquitous helminthic infections. Helminthic infections provided strong selective pressure for the dissemination of gene variants, many of which predispose to development of IBD. In animal models of IBD, helminth colonization suppresses intestinal inflammation through multiple mechanisms including induction of innate and adaptive regulatory circuits. Trials using helminths like hookworm (Necator americanus) or porcine whipworm (Trichuris suis) show that they are safe and may be effective therapies for the control of the aberrant intestinal inflammation seen in Crohn's disease and ulcerative colitis. SUMMARY: Evidence is accumulating that highly hygienic living conditions create risk for developing immune-mediated disease such as IBD. To live in their host, helminths have developed the ability to activate cells of innate and adaptive immunity that suppress inflammation. Therapeutic trials using helminths are in progress.

Indexed as

AnimalsDisease Models, AnimalHelminthiasisHelminthsHumansHygiene HypothesisImmunity, MucosalInflammationInflammatory Bowel DiseasesIntestinal MucosaSocioeconomic FactorsTherapy with Helminths

Identifiers

PMID23079675
PMCPMC3744105
OpenAlexW2030413123

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.